Interactions of a Small Linear Cationic Peptide with Lipopolysaccharide and Lipoteichoic Acid

Kurume Medical Journal

Volumn 50, Issue 3-4, 2003, Pages 99-107

  Hamamoto, Kumiko ^a   Shimizu, Takashi ^a   Kida, Yutaka ^a   Kuwano, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimicrobial peptide; Cationic peptide; LPS; LTA

Indexed keywords

CATIONIC PEPTIDE; CYTOKINE; GRANULYSIN; L PEPTIDE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN INTERACTION;

EID: 1042303492     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.50.99     Document Type: Article

References (39)

1. Hancock REW, and Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother 1999; 43:1317-1323.
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415:389-395.
3. Pena SV, Hanson DA, Carr BA, Goralski TJ, and Krensky AM. Processing, subcellular localization, and function of 519 (Granulysin), a human late T Cell activation molecule with homology to small, lytic, granule proteins. J Immunol 1997; 158:2680-2688.
4. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282:121-125.
5. Andersson M, Gunne H, Agerberth B, Boman A, Bergman T et al. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J 1995; 14:1615-1625.
6. Wang Z, Choice E, Kaspar A, Hanson D, Okada S et al. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J Immunol 2000; 165:1486-1490.
7. Hancock REW. Peptide antibiotics. Lancet 1997; 349:418-422.
8. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J et al. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63:1291-1297.
9. Piers KL, Brown MH, and Hancock REW. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother 1994; 38:2311-2316.
10. Christensen B, Fink J, Merrifield RB, and Mauzerall D. Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Natl Acad Sci U S A 1988; 85:5072-5076.
11. Wu M, and Hancock REW. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 1999; 274:29-35.
12. Hill CP, Yee J, Selsted ME, and Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 1991; 251:1481-1485.
13. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975; 72:3666-3670.
14. Hazuda DJ, Lee JC, and Young PR. The kinetics of interleukin I secretion from activated monocytes. Differences between interleukin I alpha and interleukin 1 beta. J Biol Chem 1988; 263:8473-8479.
15. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, and Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-338.
16. Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, VanOtteren GM et al. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun 1994; 62:119-125.
17. Wakabayashi G, Gelfand JA, Jung WK, Connolly RJ, Burke JF et al. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J Clin Invest 1991; 87:1925-1935.
18. Keller R, Fischer W, Keist R, and Bassetti S. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect Immun 1992; 60:3664-3672.
19. Cerami A, and Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 1988; 9:28-31.
20. Wheeler, AP, and Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340:207-214.
21. Kirikae T, Hirata M, Yamasu H, Kirikae F, Tamura H et al. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun 1998; 66:1861-1868.
22. + cells. J Immunol 2001; 167:3329-3338.
23. Gough M, Hancock REW, and Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 1996; 64:4922-4927.
24. Little RG, Kelner DN, Lim E, Burke DJ, and Conlon PJ. Functional domains of recombinant bacterial/permeability increasing protein (rBPI23). J Biol Chem 1994; 269:1865-1872.
25. Andersson M, Girard R, and Cazenave PA. Interaction of NK Lysin, a peptide produced by cytolytic lymphocytes, with endotoxin. Infect Immun 1999; 67:201-205.
26. Scott MG, Vreugdenhil ACE, Buurman WA, Hancock REW, and Gold MR. Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 2000; 164:549-553.
27. Aderem A, and Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-787.
28. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutation in Tlr4 gene. Science 1998; 282:2085-2088.
29. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Del PMS et al. Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother 2002; 46:2132-2136.
30. Iwagaki A, Porro M, and Pollack M. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14. Infect Immun 2000; 68:1655-1663.
31. Hamamoto K, Kida Y, Zhang Y, Shimizu T, and Kuwano K. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol Immunol 2002; 46:741-749.
32. Andreu D, Carreno C, Linde C, Boman HG, and Andersson M. Identification of an anti-mycobacterial domain in NK-lysin and granulysin. Biochem J 1999; 344:845-849.
33. Maloy WL, Coligan JE, and Peterson Y. Production of antipeptide antisera. In: Current protocols in Immunology, ed. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W, John Wiley & Sons, New York, Unit 9.4, 1991.
34. Kuwano K, Akashi A, Matu-ura I, Nishimoto M, and Arai S. Induction of macrophage-mediated production of tumor necrosis factor alpha by an L-form derived from Staphylococcus aureus. Infect Immun 1993; 61:1700-1706.
35. Brade L, Brandenburg K, Kuhn HM, Kusumoto S, Macher I et al. The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun 1987; 55:2636-2644.
36. Takada H, and Kotani S. Structural requirements of lipid A for endotoxicity and other biological activities. Crit Rev Microbiol 1989; 16:477-523.
37. Dankesreiter S, Hoess A, Schneider-Mergener J, Wagner H, and Miethke, T. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 2000; 164:4804-4811.
38. Scott MG, Gold MR, and Hancock REW. Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect Immun 1999; 67:6445-6453.
39. Bals R, Goldman MJ, and Wilson JM. Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun 1998; 66:1225-1232.